Baudax Bio, Inc.
BXRX
|
$0.1864
-54.35%
330K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-92.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-0.34% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 1,710,656
http://www.baudaxbio.com
Sec Filling | Patents | 25 employees
Baudax Bio, Inc. is a pharmaceutical company focusing on developing and commercializing products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.
Drugs
Anjeso (meloxicam)add to watch list Paper trade email alert is off
Press-releases
Delisting of Securities of Sono Group N.V.; Baudax Bio, Inc.; Comera Life Sciences Holdings, Inc.; Missfresh Limited; Rose Hill Acquisition Corporation; Axcella Health; Zivo Bioscience, Inc.; Sonic Foundry, Inc.; Mobiquity Technologies, Inc.; Cuentas, Inc.; micromobility.com Inc.; Harbor Custom Development, Inc.; Nogin, Inc.; Disruptive Acquisition Corporation I; Ebix, Inc.; and Aurora Technology Acquisition Corp. from The Nasdaq Stock Market
Published: 2024-02-13 (Crawled : 21:00) - globenewswire.com
SEVCQ | $0.036 51.57% 29K
|
n/a
|
| O: -7.69%
H: 46.67%
C: 11.83%
CMRA | $0.0595 70.59% 1.5K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -8.0%
MOBQ | $0.72 -65.45% 16K
|
|
| O: -14.63%
H: 17.14%
C: 8.57%
NDAQ | News | $60.01 -0.03% -0.03% 2.8M
|
Finance
|
| O: 0.65%
H: 0.23%
C: -0.45%
nasdaq rose life corporation group acquisition sciences technology market
Baudax Bio Announces Corporate Update
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 25.86%
H: 1.16%
C: -18.31%
update
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
Published: 2023-09-28 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 87.57%
H: 38.62%
C: -19.67%
ti-168 fda drug granted treatment designation
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
Published: 2023-09-07 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.04%
H: 2.56%
C: 1.28%
conference global
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Published: 2023-08-23 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 6.03%
H: 0.0%
C: -4.53%
distribution
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-08-17 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -6.11%
H: 5.53%
C: 0.4%
nasdaq direct offering
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -3.48%
H: 0.0%
C: 0.0%
business update financial results
Baudax Bio Acquires TeraImmune, Inc.
Published: 2023-06-30 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 23.03%
H: 123.42%
C: 82.81%
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-06-07 (Crawled : 13:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 7.16%
H: 5.23%
C: -2.57%
bx1000 positive trial results phase 2
Baudax Bio Announces Date of Reconvened Annual Meeting
Published: 2023-06-06 (Crawled : 13:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.85%
H: 2.91%
C: 1.8%
meeting
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10